Neoplasia — MCQs

Neoplasia Indian Medical PG Practice Questions and MCQs

Question 271: Which among the following is a marker for testicular carcinoma?

A. PSA
B. b-HCG (Correct Answer)
C. LH
D. FSH

Explanation: **Explanation:** **Why b-HCG is the correct answer:** Beta-human chorionic gonadotropin (b-HCG) is a glycoprotein hormone normally produced by syncytiotrophoblasts in the placenta. In the context of testicular neoplasia, it serves as a vital serum tumor marker. It is most characteristically elevated in **Choriocarcinoma** (100% of cases) [1] and is also found in approximately 10–15% of **Seminomas** (specifically those containing syncytiotrophoblastic giant cells) [2]. Monitoring b-HCG levels is essential for diagnosis, staging, and assessing treatment response or recurrence. **Analysis of Incorrect Options:** * **A. PSA (Prostate-Specific Antigen):** This is a highly specific marker for **Prostate Cancer** and benign prostatic hyperplasia (BPH). It has no diagnostic value for testicular malignancies. * **C & D. LH and FSH:** Luteinizing Hormone and Follicle-Stimulating Hormone are gonadotropins produced by the anterior pituitary. While they are involved in the hypothalamic-pituitary-gonadal axis, they are not secreted by testicular tumors and are not used as oncological markers. **High-Yield Clinical Pearls for NEET-PG:** * **Alpha-Fetoprotein (AFP):** Another crucial testicular marker. It is elevated in **Yolk Sac Tumors** (Endodermal sinus tumors) but is **never** elevated in pure Seminomas. * **LDH (Lactate Dehydrogenase):** A non-specific marker used to assess the overall tumor burden and growth rate in germ cell tumors. * **Schiller-Duval Bodies:** The characteristic histological finding in Yolk Sac Tumors. * **Reinke Crystals:** Pathognomonic histological finding in **Leydig Cell Tumors** (non-germ cell tumors). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, p. 982. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lower Urinary Tract and Male Genital System, pp. 980-982.

Question 272: If DNA is damaged in the cell cycle, which gene causes cell cycle arrest?

A. Rb
B. MYC
C. p53 (Correct Answer)
D. K-RAS

Explanation: **Explanation:** **p53: The Guardian of the Genome** The correct answer is **p53**. It is a tumor suppressor gene located on chromosome 17p [1], [2]. When DNA damage occurs (due to radiation, chemicals, or replication errors), p53 levels rise. It acts as a molecular "brake" by inducing the transcription of **p21**, a Cyclin-Dependent Kinase inhibitor (CDKi) [1]. p21 inhibits the Cyclin-CDK complexes, preventing the phosphorylation of Rb and causing **cell cycle arrest in the G1 phase** [1], [2]. This allows time for DNA repair; if the damage is irreparable, p53 triggers apoptosis via the BAX/BAK pathway [4]. **Analysis of Incorrect Options:** * **Rb (Retinoblastoma Gene):** Known as the "Governor of the Genome," Rb controls the G1-S checkpoint by sequestering E2F transcription factors. While it regulates the cycle, it does not directly sense DNA damage; it is the downstream effector that p53/p21 act upon [3]. * **MYC:** This is a proto-oncogene that acts as a transcriptional activator. It promotes cell proliferation and growth; its overexpression is linked to Burkitt Lymphoma. * **K-RAS:** This is a proto-oncogene involved in the MAP kinase signaling pathway. Mutations in K-RAS lead to constitutive activation of growth signals, commonly seen in pancreatic and colon cancers [4]. **High-Yield Clinical Pearls for NEET-PG:** * **Li-Fraumeni Syndrome:** A germline mutation in p53 leading to multiple early-onset cancers (Sarcoma, Breast, Leukemia, Adrenal - SBLA). * **Most Common Mutation:** p53 is the most frequently mutated gene in human cancers [2]. * **HPV Link:** The E6 protein of Human Papillomavirus (HPV) degrades p53, while E7 inhibits Rb. * **Quiescence vs. Senescence:** p53-induced arrest is called *Quiescence* (temporary) or *Senescence* (permanent) [4]. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 302-303. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 227-228. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 297-298. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 303-304.

Question 273: Regarding oncogenesis, which of the following is false?

A. Proto-oncogenes can be activated by chromosomal translocation.
B. Malignant transformation involves the accumulation of mutations in proto-oncogenes and tumor suppressor genes.
C. Point mutations can occur in somatic cells.
D. An increase in telomerase activity promotes anti-tumor effects. (Correct Answer)

Explanation: ### Explanation **Correct Answer: D. An increase in telomerase activity promotes anti-tumor effects.** **Why Option D is False (The Concept):** In normal somatic cells, telomeres shorten with each cell division, eventually leading to replicative senescence (the "Hayflick limit"). To achieve **replicative immortality**, cancer cells must overcome this [1]. Approximately 85-95% of cancers show **increased telomerase activity**, which maintains telomere length, preventing senescence and allowing indefinite cell division. Therefore, increased telomerase activity is **pro-tumorigenic**, not anti-tumor. **Analysis of Other Options:** * **Option A:** True. Chromosomal translocations can activate proto-oncogenes by placing them under the control of highly active promoters (e.g., *MYC* in Burkitt Lymphoma, t(8;14)) or by creating fusion proteins with constitutive activity (e.g., *BCR-ABL* in CML, t(9;22)) [3], [4]. * **Option B:** True. Carcinogenesis is a multi-step process. It requires the "gain of function" in proto-oncogenes (becoming oncogenes) and the "loss of function" in tumor suppressor genes (like *TP53* or *RB*) [5]. * **Option C:** True. Point mutations in somatic cells are a hallmark of sporadic cancers. A classic example is the *RAS* gene mutation, where a single nucleotide change leads to a constitutively active protein [2]. **NEET-PG High-Yield Pearls:** * **Telomerase:** It is a specialized RNA-dependent DNA polymerase (Reverse Transcriptase). * **ALT Pathway:** Some tumors maintain telomeres via "Alternative Lengthening of Telomeres" (DNA recombination) instead of telomerase. * **Knudson’s Two-Hit Hypothesis:** Applies to tumor suppressor genes; both alleles must be inactivated for phenotypic expression of cancer. * **Most common target for genetic alteration in human cancer:** *TP53* gene (Guardian of the Genome). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 312. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 229-230. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 225-226. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 310-311. [5] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 228-229.

Question 274: All of the following tumors may be malignant except?

A. Glioma
B. Astrocytoma
C. Hemangioblastoma (Correct Answer)
D. Ependymoma

Explanation: ### Explanation The correct answer is **Hemangioblastoma**. In pathology, the suffix **"-oma"** usually denotes a benign tumor (e.g., Lipoma, Adenoma) [2]. However, there are several "false friends"—tumors ending in "-oma" that are actually malignant. This question tests the ability to distinguish between these and truly benign CNS tumors. **1. Why Hemangioblastoma is the correct answer:** Hemangioblastoma is a **WHO Grade 1 (benign)**, slow-growing vascular tumor. It typically occurs in the cerebellum and is highly associated with **Von Hippel-Lindau (VHL) syndrome** [1]. While it can cause significant morbidity due to its location and associated peritumoral edema/cysts, it does not metastasize and is not considered a malignant neoplasm. **2. Analysis of Incorrect Options:** * **Gliomas (A, B, and D):** This is a broad category of neuroepithelial tumors. Unlike mesenchymal tumors, most primary CNS glial tumors are considered **biologically malignant** because they are locally invasive, lack a capsule, and have a high tendency for recurrence or progression to higher grades [3]. * **Astrocytoma (B):** These range from Grade 2 (Diffuse) to Grade 4 (Glioblastoma) [3]. Even low-grade astrocytomas are considered "malignant" in the context of the CNS because they infiltrate brain parenchyma. * **Ependymoma (D):** These are glial tumors arising from the lining of the ventricles. Most are WHO Grade 2 or 3 and are considered malignant due to their potential for local invasion and "drop metastasis" through the CSF [4]. **3. NEET-PG High-Yield Pearls:** * **"Malignant Omas":** Remember the mnemonic **M**EL**S**: **M**elanoma, **E**pithelioma (some types), **L**ymphoma, **S**eminoma/Sarcoma/**S**chwannoma (Malignant Peripheral Nerve Sheath Tumor). * **Hemangioblastoma Key Fact:** It is characterized histologically by "vacuolated stromal cells" and a rich capillary network [1]. It can produce **Erythropoietin**, leading to secondary polycythemia. * **CNS Grading:** Unlike other systems, the WHO CNS classification considers almost all neuroepithelial tumors (except a few like Pilocytic Astrocytoma or Hemangioblastoma) to have malignant potential. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Manifestations Of Central And Peripheral Nervous System Disease, pp. 726-727. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 208-209. [3] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Manifestations Of Central And Peripheral Nervous System Disease, pp. 725-726. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1312-1313.

Question 275: Carcinoembryonic antigen is raised in which of the following non-neoplastic conditions?

A. Hepatitis
B. Pancreatitis (Correct Answer)
C. Hemolytic anemia
D. Ulcerative colitis

Explanation: **Explanation:** Carcinoembryonic Antigen (CEA) is a high-molecular-weight glycoprotein normally produced during fetal development in the gastrointestinal tract and liver. In adults, it is primarily used as a **tumor marker** for colorectal carcinoma, but it lacks specificity because it can be elevated in several benign inflammatory conditions. **Why Pancreatitis is correct:** CEA levels are frequently elevated in **Pancreatitis** (both acute and chronic) and other inflammatory conditions of the GI tract. The elevation occurs due to increased cell turnover and the release of the antigen from damaged ductal epithelial cells into the systemic circulation. While CEA is not used for diagnosing pancreatitis, its elevation in such cases can lead to false-positive results when screening for malignancies. **Analysis of Incorrect Options:** * **Hepatitis:** While **Liver Cirrhosis** is a well-known cause of raised CEA, uncomplicated viral hepatitis is generally not a classic association compared to the significant elevations seen in pancreatitis or cirrhosis. * **Hemolytic Anemia:** This condition involves the destruction of red blood cells. CEA is an epithelial cell marker; therefore, hematological disorders do not typically cause an increase in CEA levels. * **Ulcerative Colitis:** While inflammatory bowel diseases (IBD) like Ulcerative Colitis can cause mild CEA elevations, **Pancreatitis** is the more classically cited non-neoplastic cause in standardized pathology examinations for this specific question context. **High-Yield Clinical Pearls for NEET-PG:** * **Primary Use:** CEA is the best marker for monitoring **recurrence** and response to therapy in **Colorectal Carcinoma**; it is NOT used for primary screening. * **Other Neoplastic Causes:** Gastric, pancreatic, breast, and medullary thyroid carcinoma. * **Other Non-Neoplastic Causes:** Heavy **smoking** (most common cause of mild elevation), Alcoholic Cirrhosis, Diverticulitis, and COPD. * **Rule of Thumb:** If a patient is a smoker, the "normal" cutoff for CEA is higher (up to 5 ng/mL) compared to non-smokers (up to 2.5 ng/mL).

Question 276: An 8-year-old African boy presents with swelling in his jaw and massive facial disfiguration. Biopsy reveals a tumor invading the bone marrow of the jaw. The pathogenesis of this malignant neoplasm is associated with a virus that exhibits a tropism for which of the following cells?

A. Chondrocytes
B. Fibroblasts
C. Lymphocytes (Correct Answer)
D. Macrophages

Explanation: ### Explanation **Correct Option: C. Lymphocytes** The clinical presentation describes a classic case of **Endemic (African) Burkitt Lymphoma** [3]. This B-cell neoplasm is strongly associated with the **Epstein-Barr Virus (EBV)** [1]. EBV exhibits a specific tropism for **B-lymphocytes** [2]. The virus enters B-cells via the **CD21 receptor** (also known as CR2) [2]. Once inside, it leads to the immortalization of the cells. In Burkitt Lymphoma, this is further complicated by a characteristic chromosomal translocation, most commonly **t(8;14)**, which results in the overexpression of the **c-MYC oncogene**, driving rapid cellular proliferation. **Analysis of Incorrect Options:** * **A. Chondrocytes:** These are cartilage cells. While tumors like chondrosarcomas exist, they are not associated with EBV or this specific clinical presentation. * **B. Fibroblasts:** These cells are involved in connective tissue formation. While some viruses (like HHV-8) affect mesenchymal cells, EBV does not target fibroblasts for the pathogenesis of Burkitt Lymphoma. * **D. Macrophages:** While macrophages are part of the tumor microenvironment (giving rise to the "starry sky" appearance as they ingest apoptotic debris), they are not the primary cell of origin or the target of viral tropism in this malignancy [4]. **NEET-PG High-Yield Pearls:** * **Morphology:** Histology shows a **"Starry Sky" appearance** (sheets of small non-cleaved lymphocytes with interspersed tingible body macrophages) [4]. * **Genetics:** **t(8;14)** is the hallmark; involves *c-MYC* (Ch 8) and *IgH* (Ch 14). * **Clinical Variants:** * *Endemic:* Jaw involvement (common in Africa, 100% EBV association) [1], [3]. * *Sporadic:* Abdominal/Ileocecal involvement (lower EBV association) [3]. * **Diagnosis:** High Ki-67 index (nearly 100%), indicating extremely rapid cell turnover. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 219-220. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Infectious Diseases, pp. 368-369. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, pp. 605-606. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of White Blood Cells, Lymph Nodes, Spleen, and Thymus, p. 606.

Question 277: Homer Wright rosettes are seen in which of the following neoplasms?

A. Neuroblastoma (Correct Answer)
B. Nephroblastoma
C. Ependymoma
D. Rhabdomyosarcoma

Explanation: **Explanation:** **Homer Wright rosettes** are a hallmark histological feature of primitive neuroectodermal tumors. They consist of a halo of tumor cells surrounding a central **fibrillar core** (neuropil), without a central lumen or blood vessel [1]. 1. **Why Neuroblastoma is correct:** Neuroblastoma is a classic "small round blue cell tumor" of childhood arising from neural crest cells [2]. The presence of Homer Wright rosettes indicates neuroaxonal differentiation [1]. These rosettes are also characteristically seen in **Medulloblastoma** and **Retinoblastoma** [1], [2]. 2. **Why other options are incorrect:** * **Nephroblastoma (Wilms Tumor):** Characterized by a "triphasic" appearance consisting of blastemal, stromal, and epithelial (primitive tubules/glomeruli) elements [2]. It does not form Homer Wright rosettes. * **Ependymoma:** Classically shows **Perivascular pseudorosettes** (cells arranged around a central blood vessel) and **True Ependymal rosettes** (Flexner-Wintersteiner-like, with a central hollow lumen) [3]. * **Rhabdomyosarcoma:** A soft tissue sarcoma showing skeletal muscle differentiation. Histology typically shows "racket-shaped" rhabdomyoblasts (tadpole cells) and cross-striations, not rosettes. **High-Yield Clinical Pearls for NEET-PG:** * **Homer Wright Rosettes:** Pseudorosettes (no lumen); seen in Neuroblastoma, Medulloblastoma, PNET/Ewing’s sarcoma [1]. * **Flexner-Wintersteiner Rosettes:** True rosettes (central lumen); highly specific for **Retinoblastoma**. * **Perivascular Pseudorosettes:** Seen in **Ependymoma** and Glioblastoma Multiforme [3]. * **Neuroblastoma Marker:** Elevated urinary catecholamines (VMA and HVA) and N-myc amplification (poor prognosis). **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Diseases of Infancy and Childhood, pp. 484-485. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 211-212. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1312-1313.

Question 278: Which neoplasm is associated with pure red cell aplasia?

A. Thymus (Correct Answer)
B. Breast
C. Hepatocellular carcinoma
D. Bronchogenic carcinoma

Explanation: **Explanation:** **Pure Red Cell Aplasia (PRCA)** is a rare hematological condition characterized by a severe reduction in erythroid precursors in the bone marrow, leading to isolated anemia [1]. **Why Thymoma is the Correct Answer:** The association between **Thymoma** (neoplasm of the thymus) and PRCA is a classic paraneoplastic syndrome. Approximately **5% to 15%** of patients with thymoma develop PRCA, and conversely, about 30% of adults with PRCA are found to have a thymoma [2]. The underlying mechanism is **autoimmune-mediated**; it is believed that T-cells or IgG antibodies directed against erythroid progenitor cells or erythropoietin lead to the selective destruction of the erythroid lineage [2]. Surgical removal of the thymoma can lead to hematological remission in many cases. **Why Other Options are Incorrect:** * **Breast Cancer:** Typically associated with paraneoplastic syndromes like hypercalcemia (via PTHrP) or dermatomyositis, but not PRCA. * **Hepatocellular Carcinoma (HCC):** Commonly associated with **erythrocytosis** (polycythemia) due to the ectopic production of Erythropoietin (EPO), which is the opposite of aplasia. * **Bronchogenic Carcinoma:** Small cell lung cancer is famous for SIADH and ACTH production, while Squamous cell carcinoma causes hypercalcemia. They do not typically cause PRCA. **High-Yield Clinical Pearls for NEET-PG:** * **Thymoma Associations:** Remember the "Triple Threat": **Myasthenia Gravis** (most common), **Pure Red Cell Aplasia**, and **Hypogammaglobulinemia** (Good’s Syndrome) [2]. * **Other causes of PRCA:** Parvovirus B19 infection (especially in sickle cell patients), SLE, and certain drugs [1]. * **Diagnosis:** Bone marrow biopsy showing a complete absence of erythroid precursors with normal myeloid and megakaryocytic lines [1]. **References:** [1] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Blood And Bone Marrow Disease, pp. 595-596. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. Common Clinical Problems From Diseases Of The Urinary And Male Genital Tracts, pp. 572-574.

Question 279: Cancer suppressor genes are important in which of the following malignancies?

A. Retinoblastoma (Correct Answer)
B. Malignant melanoma
C. Liver carcinoma
D. Lung cancer

Explanation: **Explanation:** The correct answer is **Retinoblastoma (Option A)**. This question tests the fundamental concept of **Tumor Suppressor Genes (TSGs)**, also known as anti-oncogenes. **Why Retinoblastoma is correct:** The *RB1* gene, located on chromosome **13q14**, was the first tumor suppressor gene ever discovered [1][2]. It encodes the pRB protein, which acts as a critical "molecular brake" on the cell cycle by binding to the E2F transcription factor, preventing the transition from the G1 to the S phase [5]. According to **Knudson’s "Two-Hit" Hypothesis**, both alleles of the *RB1* gene must be inactivated for malignancy to develop [1][2]. This gene is the prototypical example of how the loss of a cancer suppressor gene leads directly to tumorigenesis [3]. **Why other options are incorrect:** * **Malignant Melanoma (B):** While mutations in TSGs like *CDKN2A* (p16) can occur, melanoma is more strongly associated with gain-of-function mutations in **proto-oncogenes** like *BRAF* (V600E) and *NRAS* [4]. * **Liver Carcinoma (C):** Hepatocellular carcinoma is primarily linked to chronic inflammation (HBV/HCV) and chemical carcinogens (Aflatoxin B1), which cause TP53 mutations, but it is not the classic model for TSG study like Retinoblastoma. * **Lung Cancer (D):** Lung cancer involves a complex interplay of oncogenes (e.g., *EGFR*, *ALK*, *KRAS*) and TSGs (e.g., *TP53*, *RB*), but it is not defined by a single suppressor gene in the same foundational way as Retinoblastoma [4]. **High-Yield Clinical Pearls for NEET-PG:** * **Knudson’s Hypothesis:** Explains why hereditary retinoblastoma occurs earlier and is often bilateral (one "hit" is inherited), whereas sporadic cases occur later and are unilateral [1][2]. * **pRB Function:** When **hypophosphorylated**, pRB is active (inhibits E2F); when **hyperphosphorylated** (by Cyclin D-CDK4/6), it becomes inactive, allowing cell cycle progression [5]. * **Associated Tumors:** Patients with germline *RB1* mutations have a high risk of developing **Osteosarcoma** later in life. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, p. 300. [2] Cross SS. Underwood's Pathology: A Clinical Approach. 6th ed. (Basic Pathology) introduces the student to key general principles of pathology, both as a medical science and as a clinical activity with a vital role in patient care. Part 2 (Disease Mechanisms) provides fundamental knowledge about the cellular and molecular processes involved in diseases, providing the rationale for their treatment. Part 3 (Systematic Pathology) deals in detail with specific diseases, with emphasis on the clinically important aspects., pp. 227-228. [3] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 298-300. [4] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 297-298. [5] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. Neoplasia, pp. 300-301.

Question 280: What is the most common site of metastasis for lung carcinoma?

A. Liver
B. Kidney
C. Brain (Correct Answer)
D. Adrenals

Explanation: **Explanation:** Lung carcinoma is notorious for its early and widespread hematogenous dissemination. While it can spread to various organs, the **Brain** is considered the most common site of metastasis for lung cancer (specifically Small Cell Lung Cancer and Adenocarcinoma) [2]. Approximately 20–40% of patients with lung cancer will develop brain metastases during the course of their disease. This occurs because cancer cells enter the pulmonary veins, reach the left heart, and are pumped directly into the systemic circulation, where the brain receives a high proportion of cardiac output. **Analysis of Options:** * **Adrenals (Option D):** This is a high-yield distractor. The adrenals are the **most characteristic** or "favorite" site of metastasis for lung cancer (often found incidentally on autopsy), but in terms of absolute frequency in clinical practice, the brain is more common [1]. * **Liver (Option A):** The liver is a very common site for many visceral malignancies (like GI tract cancers) due to portal circulation, but it ranks behind the brain and adrenals for primary lung malignancies [1]. * **Kidney (Option B):** While lung cancer can spread to the kidneys, it is significantly less frequent than the brain, liver, or bone [1, 2]. **NEET-PG High-Yield Pearls:** * **Most common site of metastasis for Lung Cancer:** Brain. * **Most common site of metastasis *to* the Brain:** Lung Cancer (followed by Breast and Melanoma) [2]. * **Most common site for "Silent" metastasis in Lung Cancer:** Adrenal glands [1]. * **Sentinel finding:** If a patient presents with a new-onset seizure and a cough, always suspect lung carcinoma with brain metastasis. **References:** [1] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Lung, pp. 724-725. [2] Kumar V, Abbas AK, et al.. Robbins and Cotran Pathologic Basis of Disease. 9th ed. The Central Nervous System, pp. 1317-1318.

Practice by Chapter

Nomenclature and Classification of Tumors

Practice Questions

Characteristics of Benign and Malignant Neoplasms

Practice Questions

Molecular Basis of Cancer

Practice Questions

Carcinogenesis and Carcinogens

Practice Questions

Tumor Progression and Metastasis

Practice Questions

Tumor Markers

Practice Questions

Paraneoplastic Syndromes

Practice Questions

Genetic Basis of Cancer

Practice Questions

Tumor Immunity

Practice Questions

Cancer Epidemiology and Prevention

Practice Questions

Want unlimited practice?

Get full access to all questions, explanations, and performance tracking.

Start For Free

Neoplasia — MCQs

Neoplasia — MCQs

On this page

Practice by Chapter

Want unlimited practice?